<html><head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" /><meta http-equiv="Content-Style-Type" content="text/css" /><meta name="generator" content="Aspose.Words for .NET 13.4.0.0" /><title>EPSRC IRC in Early Warning Sensing Systems for Infectious Diseases</title></head><body><div><p style="margin:0pt; text-align:center"><span style="font-family:Arial; font-size:10pt; font-style:italic">EPSRC IRC Submission of Evidence to the Select Committee Inquiry into AMR</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p><p style="margin:0pt; orphans:0; text-align:center; widows:0"><span style="font-family:Arial; font-size:10pt; font-weight:bold">EPSRC IRC Submission of Evidence to the House of Commons Science &amp; Technology </span></p><p style="margin:0pt; orphans:0; text-align:center; widows:0"><span style="font-family:Arial; font-size:10pt; font-weight:bold">Select Committee Inquiry into Antimicrobial Resistance </span></p><p style="margin:0pt; orphans:0; text-align:center; widows:0"><span style="font-family:Arial; font-size:10pt">6</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">th</span><span style="font-family:Arial; font-size:10pt"> November 2013.</span></p><table cellspacing="0" cellpadding="0" style="border-collapse:collapse; float:left; margin:0pt 9pt"><tr><td style="background-color:#dbe5f1; border-bottom-color:#000000; border-bottom-style:solid; border-bottom-width:0.5pt; border-left-color:#000000; border-left-style:solid; border-left-width:0.5pt; border-right-color:#000000; border-right-style:solid; border-right-width:0.5pt; border-top-color:#000000; border-top-style:solid; border-top-width:0.5pt; padding-left:5.4pt; padding-right:5.4pt; vertical-align:top; width:534.1pt"><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-style:italic; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">1.0 </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Executive </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Summary</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-style:italic">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">The emergence of antimicrobial resistance (AMR) is one of the gravest threats to public health. We strongly support the Government’s UK 5 Year AMR Strategy 2013-18 but identify notable gaps in the development of next-generation diagnostics and surveillance technologies. </span></li></ul><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">We recommend prioritising two key areas of research: (</span><span style="font-family:Arial; font-size:10pt">i</span><span style="font-family:Arial; font-size:10pt">) Web-tracking and crowd-sourcing for the early identification of outbreaks; (ii) The development of rapid diagnostics with data linkage for use in community settings, for example </span><span style="font-family:Arial; font-size:10pt">smartphone</span><span style="font-family:Arial; font-size:10pt">–connected tests; </span></li></ul><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 27.6pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">Core</span><span style="font-family:Arial; font-size:10pt"> engineering and physical sciences research is needed to create a pipeline of 21</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">st</span><span style="font-family:Arial; font-size:10pt"> century technologies to address AMR. Prioritising these areas will ensure that the NHS is best placed to take advantage of emerging technologies to tackle AMR, and will also provide commercial opportunities for British industry.</span></li></ul><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-style:italic">&#xa0;</span></p></td></tr></table><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 21.3pt; text-align:justify; text-indent:-21.3pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">2.0 </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Who we are:</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">We are a new EPSRC Interdisciplinary Research Collaboration</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">(IRC) </span><span style="font-family:Arial; font-size:10pt">which aims to develop an Early Warning Sensing System for Infectious Diseases. </span><span style="font-family:Arial; font-size:10pt">The IRC brings together </span><span style="font-family:Arial; font-size:10pt">multidisciplinary teams of </span><span style="font-family:Arial; font-size:10pt">scientists, engineers and clinicians from UCL, Imperial College, the London School of Hygiene and Tropical Medicine, Newcastle University and Surrey University, together with NHS stakeholders</span><span style="font-family:Arial; font-size:10pt">,</span><span style="font-family:Arial; font-size:10pt"> UCL Partners, Public Health England and industry partners.</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">We are pleased to m</span><span style="font-family:Arial; font-size:10pt">ake a short submission </span><span style="font-family:Arial; font-size:10pt">to the Select Committ</span><span style="font-family:Arial; font-size:10pt">ee’s inquiry into AMR</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">1</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">and focus on the Committee’s questions regarding gaps in </span><span style="font-family:Arial; font-size:10pt">our </span><span style="font-family:Arial; font-size:10pt">knowledge </span><span style="font-family:Arial; font-size:10pt">of AMR </span><span style="font-family:Arial; font-size:10pt">and </span><span style="font-family:Arial; font-size:10pt">recommend </span><span style="font-family:Arial; font-size:10pt">prioritizing</span><span style="font-family:Arial; font-size:10pt"> fut</span><span style="font-family:Arial; font-size:10pt">ure</span><span style="font-family:Arial; font-size:10pt"> research</span><span style="font-family:Arial; font-size:10pt"> in next generation diagnostics and surveillance</span><span style="font-family:Arial; font-size:10pt">.</span></p><p style="margin:0pt 0pt 0pt 36pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">3.0</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">How has AMR developed in the past decade?</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">3.1</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">A key factor driving the development of AMR is </span><span style="font-family:Arial; font-size:10pt">the lack of rapid diagnostic and </span><span style="font-family:Arial; font-size:10pt">disease </span><span style="font-family:Arial; font-size:10pt">surveillance technologies </span><span style="font-family:Arial; font-size:10pt">to </span><span style="font-family:Arial; font-size:10pt">detect early-stage infections in community settings.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">1</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">-6</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">The</span><span style="font-family:Arial; font-size:10pt"> result is that</span><span style="font-family:Arial; font-size:10pt"> worldwide many infections remain undiagnosed or are diagnosed at a late stage. This leads to on-going transmission </span><span style="font-family:Arial; font-size:10pt">by </span><span style="font-family:Arial; font-size:10pt">people</span><span style="font-family:Arial; font-size:10pt"> unaware of their infections</span><span style="font-family:Arial; font-size:10pt"> and</span><span style="font-family:Arial; font-size:10pt"> widespread inappropriate use of antibiotics which fuels drug-</span><span style="font-family:Arial; font-size:10pt">resistance. Late diagnosis</span><span style="font-family:Arial; font-size:10pt"> also </span><span style="font-family:Arial; font-size:10pt">limits</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">our ability to </span><span style="font-family:Arial; font-size:10pt">respond to</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">emerging </span><span style="font-family:Arial; font-size:10pt">AMR strains</span><span style="font-family:Arial; font-size:10pt">.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">3.2</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Early detection plays a crucial role in all treatment and prevention strategies. </span><span style="font-family:Arial; font-size:10pt">H</span><span style="font-family:Arial; font-size:10pt">owever,</span><span style="font-family:Arial; font-size:10pt"> current gold-standard diagnostic tests </span><span style="font-family:Arial; font-size:10pt">(</span><span style="font-family:Arial; font-size:10pt">e.g. </span><span style="font-family:Arial; font-size:10pt">RT-PCR and bacterial culture) are slow and </span><span style="font-family:Arial; font-size:10pt">require samples to be sent to specialist laboratories</span><span style="font-family:Arial; font-size:10pt">. This leads to</span><span style="font-family:Arial; font-size:10pt"> inherent delays between tests, results and clinical interventions. Public health interventio</span><span style="font-family:Arial; font-size:10pt">n may be further delayed by a </span><span style="font-family:Arial; font-size:10pt">time lag of 1-2 weeks</span><span style="font-family:Arial; font-size:10pt">,</span><span style="font-family:Arial; font-size:10pt"> associated with retrospective surveillance of laboratory tests.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">3.3</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">There are national and international drivers to widen access to </span><span style="font-family:Arial; font-size:10pt">rapid </span><span style="font-family:Arial; font-size:10pt">tests at the point-of-care (</span><span style="font-family:Arial; font-size:10pt">PoC</span><span style="font-family:Arial; font-size:10pt">) but current tests (</span><span style="font-family:Arial; font-size:10pt; font-style:italic">e.g.</span><span style="font-family:Arial; font-size:10pt; font-style:italic"> </span><span style="font-family:Arial; font-size:10pt">lateral flow</span><span style="font-family:Arial; font-size:10pt"> tests</span><span style="font-family:Arial; font-size:10pt">) are typically not sensitive to early infections</span><span style="font-family:Arial; font-size:10pt">,</span><span style="font-family:Arial; font-size:10pt"> leading to missed opportunities for interventions.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">6</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">3.4</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Moreover while </span><span style="font-family:Arial; font-size:10pt">PoC</span><span style="font-family:Arial; font-size:10pt"> tests may speed diagnosis, </span><span style="font-family:Arial; font-size:10pt">this data must be captured. I</span><span style="font-family:Arial; font-size:10pt">f capability to capture information for national and international surveillance is lost, so too will our ability to respond to future threats.</span><span style="font-family:Arial; font-size:10pt"> Therefore future rapid </span><span style="font-family:Arial; font-size:10pt">PoC</span><span style="font-family:Arial; font-size:10pt"> tests must be sensitive to early infections and combined with data linkage.</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.0</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Is there sufficient research and investment into new antibiotics or other treatments and methods to ensure continued protection against infection? If not how could this be rectified?</span></p><p style="margin:0pt 0pt 0pt 18pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.1</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">In parallel with the development of new anti</span><span style="font-family:Arial; font-size:10pt">microbials</span><span style="font-family:Arial; font-size:10pt">, t</span><span style="font-family:Arial; font-size:10pt">here is a vital need for</span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt">new technologies to improve the early detection and diagnosis of infections, particularly in community settings. </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.2</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Research into new diagnostics has traditionally seen under-investment co</span><span style="font-family:Arial; font-size:10pt">mpared to treatment and vaccine programmes</span><span style="font-family:Arial; font-size:10pt"> but there is a growing realisation that diagnostics are the gateway</span><span style="font-family:Arial; font-size:10pt"> to informing correct treatment</span><span style="font-family:Arial; font-size:10pt"> and prevention strategies</span><span style="font-family:Arial; font-size:10pt">. Better diagnostics</span><span style="font-family:Arial; font-size:10pt"> will</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">curb</span><span style="font-family:Arial; font-size:10pt"> the inappropriate use of antibiotics, in turn preserving their effectiveness</span><span style="font-family:Arial; font-size:10pt"> for future generations</span><span style="font-family:Arial; font-size:10pt">.</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.3</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">We welcome the </span><span style="font-family:Arial; font-size:10pt">Government’s </span><span style="font-family:Arial; font-size:10pt">recommendation to increase funding </span><span style="font-family:Arial; font-size:10pt">in this area</span><span style="font-family:Arial; font-size:10pt"> but we note that there is no reference </span><span style="font-family:Arial; font-size:10pt">in the report </span><span style="font-family:Arial; font-size:10pt">to EPSRC research.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">1</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">There</span><span style="font-family:Arial; font-size:10pt"> is a crucial need for core underpinning engineering and physical sciences research to fuel a pipeline of innovative 21</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">st</span><span style="font-family:Arial; font-size:10pt"> century diagnostic and surveillance technologies to prevent the spread of AMR. </span><span style="font-family:Arial; font-size:10pt">We recommend prioritising research </span><span style="font-family:Arial; font-size:10pt">in </span><span style="font-family:Arial; font-size:10pt">two </span><span style="font-family:Arial; font-size:10pt">key areas: </span><span style="font-family:Arial; font-size:10pt">(</span><span style="font-family:Arial; font-size:10pt">i</span><span style="font-family:Arial; font-size:10pt">) </span><span style="font-family:Arial; font-size:10pt">Web-tracking of infectious diseases across populations; (ii) Rapid Diagnostics with Data Linkage for Community Settings. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.4</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt; font-weight:bold"> </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Web-tracking of infectious diseases across populations </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.41</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">The Government’s </span><span style="font-family:Arial; font-size:10pt">5 Year AMR Strategy 2013-18</span><span style="font-family:Arial; font-size:10pt; font-style:italic"> </span><span style="font-family:Arial; font-size:10pt">focuses on </span><span style="font-family:Arial; font-size:10pt">improving </span><span style="font-family:Arial; font-size:10pt">traditional surveillance systems.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">1</span><span style="font-family:Arial; font-size:10pt"> In addition, we recommend priorit</span><span style="font-family:Arial; font-size:10pt">ising the use of web-</span><span style="font-family:Arial; font-size:10pt">information</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">and crowd sourcing </span><span style="font-family:Arial; font-size:10pt">to improve early detection capabilities</span><span style="font-family:Arial; font-size:10pt">. </span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.42</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Every week millions of people use the internet to search for information about health and self-report symptoms of an illness, often before they visit a doctor. For example, symptoms such as “fever”</span><span style="font-family:Arial; font-size:10pt">, </span><span style="font-family:Arial; font-size:10pt">“cough” </span><span style="font-family:Arial; font-size:10pt">or “</span><span style="font-family:Arial; font-size:10pt">diarrhoea</span><span style="font-family:Arial; font-size:10pt">” </span><span style="font-family:Arial; font-size:10pt">are investigated using search engines (e.g. Google or Bing), and posted on social </span><span style="font-family:Arial; font-size:10pt">networking</span><span style="font-family:Arial; font-size:10pt"> and </span><span style="font-family:Arial; font-size:10pt">microblogging</span><span style="font-family:Arial; font-size:10pt"> sites (e.g. Twitter). Although not everyone who types in symptoms is actually ill, </span><span style="font-family:Arial; font-size:10pt">a pattern emerges from trends in the total number of </span><span style="font-family:Arial; font-size:10pt">anonymised</span><span style="font-family:Arial; font-size:10pt"> searches</span><span style="font-family:Arial; font-size:10pt"> and tweets</span><span style="font-family:Arial; font-size:10pt">.</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.43</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Up-to-date estimates of outbreaks based on web-information linked to current epidemiological information may enable doctors to better respond to AMR.</span><span style="font-family:Arial; font-size:10pt"> Web-information also has the advantage that it could potentially track infections across a much larger proportion of the population </span><span style="font-family:Arial; font-size:10pt">than current surveillance </span><span style="font-family:Arial; font-size:10pt">and might identify outbreaks even before people attend clinics. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.44</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">The low cost of these methods is likely to be of particular benefit in resource-limited settings such as developing countries, where infectious diseases are an enormous problem. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.45</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Web information and crowd sourcing has been exploited for the identification of disease outbreaks, such as influenza, at an early stage. Similar tools could be applied to AMR, in combination with rapid diagnostics. </span><span style="font-family:Arial; font-size:10pt">Key e</span><span style="font-family:Arial; font-size:10pt">xamples of these technologies </span><span style="font-family:Arial; font-size:10pt">include</span><span style="font-family:Arial; font-size:10pt">:</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 100.35pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">The Canadian Global Public Health Intelligence Network (GPHIN)</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">used web media sources to identify</span><span style="font-family:Arial; font-size:10pt"> severe acute respiratory syndrome (SARS) in China,</span><span style="font-family:Arial; font-size:10pt"> several weeks earlier than </span><span style="font-family:Arial; font-size:10pt">the World Health Organisation </span><span style="font-family:Arial; font-size:10pt">(</span><a href="http://www.phac-aspc.gc.ca/gphin/"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">www.phac-aspc.gc.ca/gphin/</span></a><span style="font-family:Arial; font-size:10pt">)</span><span style="font-family:Arial; font-size:10pt">; </span></li></ul><p style="margin:0pt 0pt 0pt 108.75pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 100.35pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">Google and the US Centre for Disease</span><span style="font-family:Arial; font-size:10pt"> Control and Prevention, </span><span style="font-family:Arial; font-size:10pt">counted the total number of flu-symptom</span><span style="font-family:Arial; font-size:10pt"> search queries to detect </span><span style="font-family:Arial; font-size:10pt">epidemics 2 weeks earlier than current public health efforts. The work was publish</span><span style="font-family:Arial; font-size:10pt">ed in the journal Nature in 2009</span><span style="font-family:Arial; font-size:10pt">.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">7</span><span style="font-family:Arial; font-size:10pt"> (</span><span style="color:#0000ff; font-family:Arial; font-size:10pt">Google Flu Trends: </span><a href="http://www.google.org/flutrends/"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">www.google.org/flutrends/</span></a><span style="color:#0000ff; font-family:Arial; font-size:10pt">)</span><span style="color:#0000ff; font-family:Arial; font-size:10pt"> </span></li></ul><p style="margin:0pt 0pt 0pt 108.75pt; text-align:justify"><span style="color:#0000ff; font-family:Arial; font-size:10pt">&#xa0;</span></p><ul type="disc" style="margin:0pt; padding-left:0pt"><li style="font-family:Symbol; font-size:10pt; margin:0pt 0pt 0pt 100.35pt; padding-left:8.4pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:10pt">Crowd-sourcing sites such as Flu Survey, developed by researchers at the London School of Hygiene and Tropical Medicine, </span><span style="font-family:Arial; font-size:10pt">recruit volunteers to report sympto</span><span style="font-family:Arial; font-size:10pt">ms and provide weekly updates on</span><span style="font-family:Arial; font-size:10pt"> the spread of flu </span><span style="font-family:Arial; font-size:10pt">(</span><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">http://flusurvey.org.uk/</span><span style="font-family:Arial; font-size:10pt">).</span><span style="font-family:Arial; font-size:10pt"> </span></li></ul><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.46</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">M</span><span style="font-family:Arial; font-size:10pt">ore</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">research</span><span style="font-family:Arial; font-size:10pt"> is needed to improve the evidence-base of these potentially highly</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">valuable technologies</span><span style="font-family:Arial; font-size:10pt"> and extend their use to AMR</span><span style="font-family:Arial; font-size:10pt">.</span><span style="font-family:Arial; font-size:10pt"> Future research</span><span style="font-family:Arial; font-size:10pt"> should target tools to improve their accuracy</span><span style="font-family:Arial; font-size:10pt">, geographical granularity and</span><span style="font-family:Arial; font-size:10pt"> evaluate</span><span style="font-family:Arial; font-size:10pt"> of their cost-effectiveness</span><span style="font-family:Arial; font-size:10pt">. </span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.47</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">We would like to highlight o</span><span style="font-family:Arial; font-size:10pt">ne of the key challenges facing the academic community in this area is restricted access to data, such as queries and tweets, held by private companies. New public-private partnerships, policy changes</span><span style="font-family:Arial; font-size:10pt">, </span><span style="font-family:Arial; font-size:10pt">governance frameworks are urgently required to responsibly develop this powerful resource for AMR, balancing the privacy of individuals with the benefits of research for the public good; </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.48</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Data linkage to current surveillance systems will </span><span style="font-family:Arial; font-size:10pt">also </span><span style="font-family:Arial; font-size:10pt">be crucial. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify; text-indent:-18.75pt"><span style="font-family:Arial; font-size:10pt">4.49</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Global coordination and action is urgently required since infectious diseases know no borders. More strategic alignment and investment is needed to support cros</span><span style="font-family:Arial; font-size:10pt">s border activities and </span><span style="font-family:Arial; font-size:10pt">global networks of excellence. </span><span style="font-family:Arial; font-size:10pt">In particular, international web surveillance efforts could be significantly strengthened by a shared open-source software platform that provides the core software platform for national programs and allows national programs to focus on unique requirements, e.g. language.</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 72.75pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">4.5</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">R</span><span style="font-family:Arial; font-size:10pt; font-weight:bold">apid Diagnostics with Data Linkage for </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">C</span><span style="font-family:Arial; font-size:10pt; font-weight:bold">ommunity Settings</span><span style="font-family:Arial; font-size:10pt">:</span></p><p style="margin:0pt 0pt 0pt 54pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.51</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">R</span><span style="font-family:Arial; font-size:10pt">apid and accurate identification </span><span style="font-family:Arial; font-size:10pt">of the underlying agents using diagnostic tests is essential if we are to stop outbreaks with the correct control measures, for instance, containment, confinement, antimicrobials or vaccines. This is particularly true fo</span><span style="font-family:Arial; font-size:10pt">r emerging resistance</span><span style="font-family:Arial; font-size:10pt">, where we find ourselves in a race to develop new controls as the disease spreads. </span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.52</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">However </span><span style="font-family:Arial; font-size:10pt">current gold standard tests are laboratory-based and </span><span style="font-family:Arial; font-size:10pt">the inherent delays associated with </span><span style="font-family:Arial; font-size:10pt">sending sample off</span><span style="font-family:Arial; font-size:10pt">, </span><span style="font-family:Arial; font-size:10pt">obtaining </span><span style="font-family:Arial; font-size:10pt">test </span><span style="font-family:Arial; font-size:10pt">results and follow up appointments leads to delays in treatment and prevention strategies</span><span style="font-family:Arial; font-size:10pt">. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.53</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">The </span><span style="font-family:Arial; font-size:10pt">Government’s 5 Year AMR Strategy 2013-18,</span><span style="font-family:Arial; font-size:10pt"> highlights the urgent need for the deployment of </span><span style="font-family:Arial; font-size:10pt">PoC</span><span style="font-family:Arial; font-size:10pt"> diagnostics in community settings to speed diagnosis. However, robust, rapid, high-performance </span><span style="font-family:Arial; font-size:10pt">PoC</span><span style="font-family:Arial; font-size:10pt"> technologies </span><span style="font-family:Arial; font-size:10pt">must </span><span style="font-family:Arial; font-size:10pt">first </span><span style="font-family:Arial; font-size:10pt">be developed</span><span style="font-family:Arial; font-size:10pt"> to ensure this capability</span><span style="font-family:Arial; font-size:10pt">. </span><span style="font-family:Arial; font-size:10pt">This will </span><span style="font-family:Arial; font-size:10pt">require significant </span><span style="font-family:Arial; font-size:10pt">future </span><span style="font-family:Arial; font-size:10pt">research into</span><span style="font-family:Arial; font-size:10pt">, for example,</span><span style="font-family:Arial; font-size:10pt"> new biomarkers</span><span style="font-family:Arial; font-size:10pt"> which reduce the need for complex sample preparation steps</span><span style="font-family:Arial; font-size:10pt">,</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">genomics, </span><span style="font-family:Arial; font-size:10pt">temperature-stable capture coatings, </span><span style="font-family:Arial; font-size:10pt">micro and </span><span style="font-family:Arial; font-size:10pt">nano</span><span style="font-family:Arial; font-size:10pt">-</span><span style="font-family:Arial; font-size:10pt">sensor systems</span><span style="font-family:Arial; font-size:10pt"> with on-chip sample handling capabilities</span><span style="font-family:Arial; font-size:10pt">, low power microelectronics</span><span style="font-family:Arial; font-size:10pt">, </span><span style="font-family:Arial; font-size:10pt">big data analytics</span><span style="font-family:Arial; font-size:10pt"> and data visualisation tools</span><span style="font-family:Arial; font-size:10pt">.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super"> </span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">8-14</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.54</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">Increased availability of cost effective and easily deployable testing allows timely, more appropr</span><span style="font-family:Arial; font-size:10pt">iate, and less costly treatment.</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">I</span><span style="font-family:Arial; font-size:10pt">t helps to rule out more expensive treatment and overtreatment, reduces </span><span style="font-family:Arial; font-size:10pt">the</span><span style="font-family:Arial; font-size:10pt"> cost of treatment complications, and potentially reduces the length of stay in hospital. </span><span style="font-family:Arial; font-size:10pt">Moving </span><span style="font-family:Arial; font-size:10pt">early diagnosis </span><span style="font-family:Arial; font-size:10pt">in</span><span style="font-family:Arial; font-size:10pt">to the community – particularly in settings such as residential homes, provides the opportunity for significant reductions in morbidity and mortality.</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.55</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">A</span><span style="font-family:Arial; font-size:10pt">s testing becomes more widespread in a variety of non-hospital settings, </span><span style="font-family:Arial; font-size:10pt">it </span><span style="font-family:Arial; font-size:10pt">will become </span><span style="font-family:Arial; font-size:10pt">vital to</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">ensure information is </span><span style="font-family:Arial; font-size:10pt">capture</span><span style="font-family:Arial; font-size:10pt">d</span><span style="font-family:Arial; font-size:10pt"> for </span><span style="font-family:Arial; font-size:10pt">disease </span><span style="font-family:Arial; font-size:10pt">surveillance. Rapid diagnostic tests with data linkage, such </span><span style="font-family:Arial; font-size:10pt">as</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">smartphone</span><span style="font-family:Arial; font-size:10pt">-connected tests, offer huge potential for rapid, real-time, geographically tagged diagnosis. This evidence can be combined with </span><span style="font-family:Arial; font-size:10pt">web-tracking efforts to map</span><span style="font-family:Arial; font-size:10pt"> outbreaks at local, national and international levels to support</span><span style="font-family:Arial; font-size:10pt"> early</span><span style="font-family:Arial; font-size:10pt"> public health interventions. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.56</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">T</span><span style="font-family:Arial; font-size:10pt">he enormous rise in mobile phones and internet usage in </span><span style="font-family:Arial; font-size:10pt">developed and </span><span style="font-family:Arial; font-size:10pt">developing countries</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">presents </span><span style="font-family:Arial; font-size:10pt">an </span><span style="font-family:Arial; font-size:10pt">exciting </span><span style="font-family:Arial; font-size:10pt">opportunity</span><span style="font-family:Arial; font-size:10pt"> to </span><span style="font-family:Arial; font-size:10pt">dramatically </span><span style="font-family:Arial; font-size:10pt">widen access to </span><span style="font-family:Arial; font-size:10pt">“smart </span><span style="font-family:Arial; font-size:10pt">diagnostics </span><span style="font-family:Arial; font-size:10pt">tests” to</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">uncover and manage infection worldwide </span><span style="font-family:Arial; font-size:10pt">- </span><span style="font-family:Arial; font-size:10pt">for the common good. </span><span style="font-family:Arial; font-size:10pt">In 2013 the International Telecommunications Union estimates that there </span><span style="font-family:Arial; font-size:10pt">are </span><span style="font-family:Arial; font-size:10pt">6.8 billion mobile subscriptions </span><span style="font-family:Arial; font-size:10pt">with</span><span style="font-family:Arial; font-size:10pt"> rapid expansion in develop</span><span style="font-family:Arial; font-size:10pt">ing countries.</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">1</span><span style="font-family:Arial; font-size:6.67pt; vertical-align:super">4</span><span style="font-family:Arial; font-size:10pt"> Widening access to tests in community settings will empower patients to gain faster access to treatment, reduce the inappropriate use of antibiotics and protect the wider public.</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.57</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">The rise in mobile health technologies is linked to a much larger trend in patients taking on much more interest and responsibility in their own health. For example, handheld glucose monitoring </span><span style="font-family:Arial; font-size:10pt">devices</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">with data linkage to doctors </span><span style="font-family:Arial; font-size:10pt">are the standard of </span><span style="font-family:Arial; font-size:10pt">care for patients with diabetes.</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">Mobile tests </span><span style="font-family:Arial; font-size:10pt">for AMR </span><span style="font-family:Arial; font-size:10pt">could also facilitate two-way interfaces, providing patients with advice on treatment (e.g. encouraging compliance to antibiotic treatment programmes) and relaying public information in the event of a serious outbreak. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.58</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">However t</span><span style="font-family:Arial; font-size:10pt">here </span><span style="font-family:Arial; font-size:10pt">remain</span><span style="font-family:Arial; font-size:10pt"> major </span><span style="font-family:Arial; font-size:10pt">scientific and </span><span style="font-family:Arial; font-size:10pt">technological challenges associated with the development of robust, high-performance tests for community settings. </span><span style="font-family:Arial; font-size:10pt">We see a need for</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">major programmes of basic research </span><span style="font-family:Arial; font-size:10pt">at the interface between physical sciences, engineering, life sciences and medicine, to </span><span style="font-family:Arial; font-size:10pt">support technology translation, </span><span style="font-family:Arial; font-size:10pt">improve </span><span style="font-family:Arial; font-size:10pt">regulatory guidance</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">and the heal</span><span style="font-family:Arial; font-size:10pt">th economic evaluation of </span><span style="font-family:Arial; font-size:10pt">new mobile health technologie</span><span style="font-family:Arial; font-size:10pt">s</span><span style="font-family:Arial; font-size:10pt">. </span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 0pt 36pt"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><p style="margin:0pt 0pt 0pt 70.9pt; text-align:justify; text-indent:-14.2pt"><span style="font-family:Arial; font-size:10pt">4.59</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt">We </span><span style="font-family:Arial; font-size:10pt">also </span><span style="font-family:Arial; font-size:10pt">recommend creating </span><span style="font-family:Arial; font-size:10pt">AMR Fellowships, </span><span style="font-family:Arial; font-size:10pt">Grand Challenge </span><span style="font-family:Arial; font-size:10pt">research </span><span style="font-family:Arial; font-size:10pt">programmes</span><span style="font-family:Arial; font-size:10pt">, </span><span style="font-family:Arial; font-size:10pt">Centres for Doctoral Training</span><span style="font-family:Arial; font-size:10pt"> and Global networks of excellence</span><span style="font-family:Arial; font-size:10pt"> in AMR</span><span style="font-family:Arial; font-size:10pt">. Cre</span><span style="font-family:Arial; font-size:10pt">ating the tools, skill-sets, </span><span style="font-family:Arial; font-size:10pt">trained </span><span style="font-family:Arial; font-size:10pt">personnel</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt">and future leaders in AMR </span><span style="font-family:Arial; font-size:10pt">will ensure that the NHS</span><span style="font-family:Arial; font-size:10pt"> is best placed to take advantage of emerging technologies to tackle AMR, and will also provide commercial opportunities for British industry.</span></p><p style="font-size:10pt; line-height:115%; margin:0pt 0pt 10pt"><br style="page-break-before:always; clear:both" /></p><p style="margin:0pt 0pt 0pt 18pt; text-align:justify; text-indent:-18pt"><span style="font-family:Arial; font-size:10pt; font-weight:bold">5.0</span><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">References</span></p><p style="margin:0pt 0pt 0pt 54.75pt; text-align:justify"><span style="font-family:Arial; font-size:10pt">&#xa0;</span></p><ol type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">UK Government’s</span><span style="font-family:Arial; font-size:9pt"> UK 5 Year AMR Strategy 2013-18, </span><span style="font-family:Arial; font-size:9pt">Department of Health;</span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">Evaluation of diagnostic tests for infectious diseases: general principles, </span><span style="font-family:Arial; font-size:9pt">Banoo</span><span style="font-family:Arial; font-size:9pt">, Bell, </span><span style="font-family:Arial; font-size:9pt">Bossuyt</span><span style="font-family:Arial; font-size:9pt">, Herring, </span><span style="font-family:Arial; font-size:9pt">Mabey</span><span style="font-family:Arial; font-size:9pt">, Poole, Smith, </span><span style="font-family:Arial; font-size:9pt">Sriram</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Wongsrichanalai</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Linke</span><span style="font-family:Arial; font-size:9pt">, O'Brien, Perkins, Cunningham, </span><span style="font-family:Arial; font-size:9pt">Matsoso</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Nathanson</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Olliaro</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Peeling</span><span style="font-family:Arial; font-size:9pt">, Ramsay </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Nature Rev. </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Microbiol</span><span style="font-family:Arial; font-size:9pt; font-style:italic">.</span><span style="font-family:Arial; font-size:9pt">, 6, S16 (2008); </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">Origins of HIV and the evolution of resistance to AIDS. </span><span style="font-family:Arial; font-size:9pt">Heeney</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Dalgleish</span><span style="font-family:Arial; font-size:9pt"> &amp; </span><span style="font-family:Arial; font-size:9pt">Weiss </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Science </span><span style="font-family:Arial; font-size:9pt">313, 462 (2006);</span><span style="font-family:Arial; font-size:9pt"> </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">HIV resistance and the developing world Gupta &amp; </span><span style="font-family:Arial; font-size:9pt">Pillay</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">D. Int. </span><span style="font-family:Arial; font-size:9pt; font-style:italic">J. </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Antimicrob</span><span style="font-family:Arial; font-size:9pt; font-style:italic">. Ag. </span><span style="font-family:Arial; font-size:9pt">29, 510 (2007);</span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">Outcomes from monitoring of patients on antiretroviral therapy in resource-limited settings with viral load, CD4 cell count, or clinical observation alone: a computer simulation model Phillips, </span><span style="font-family:Arial; font-size:9pt">Pillay</span><span style="font-family:Arial; font-size:9pt">, Miners, Bennett, </span><span style="font-family:Arial; font-size:9pt">Gilks</span><span style="font-family:Arial; font-size:9pt"> &amp; Lundgren </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Lancet </span><span style="font-family:Arial; font-size:9pt">371, 1443 (2008)</span><span style="font-family:Arial; font-size:9pt">;</span><span style="font-family:Arial; font-size:9pt"> </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">Time to test for HIV: Expanding HIV testing in healthcare and community services in England, Final Report 2011. Department of Health</span><span style="font-family:Arial; font-size:9pt">;</span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt">Detecting influenza epidemics using search engine query data. Ginsberg, </span><span style="font-family:Arial; font-size:9pt">Mohebbi</span><span style="font-family:Arial; font-size:9pt">, Patel, </span><span style="font-family:Arial; font-size:9pt">Brammer</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Smolinski</span><span style="font-family:Arial; font-size:9pt"> &amp; Brilliant </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Nature </span><span style="font-family:Arial; font-size:9pt">457, 1012 (2009);</span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt">N</span><span style="font-family:Arial; font-size:9pt">anomechanical</span><span style="font-family:Arial; font-size:9pt"> Detection of Antibiotic Drug-target interactions &amp; resistance on cantilever arrays, </span><span style="font-family:Arial; font-size:9pt">Ndieyira</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Watari</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Donoso</span><span style="font-family:Arial; font-size:9pt">-Barrera, </span><span style="font-family:Arial; font-size:9pt">Batchelor</span><span style="font-family:Arial; font-size:9pt">, Zhou, Cooper, </span><span style="font-family:Arial; font-size:9pt">Dueck</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Strunz</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Abell</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Rayment</span><span style="font-family:Arial; font-size:9pt">, </span><span style="font-family:Arial; font-size:9pt">Aeppli</span><span style="font-family:Arial; font-size:9pt">, McKendry R</span><span style="font-family:Arial; font-size:9pt; font-style:italic">A </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Nature Nanotech. </span><span style="font-family:Arial; font-size:9pt">3, 691 (2008);</span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font:7.0pt 'Times New Roman'">&#xa0;&#xa0; </span><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt">Plasmonic</span><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt">nanosensors</span><span style="font-family:Arial; font-size:9pt"> with inverse sensitivity by means of enzyme-guided crystal growth. </span><span style="font-family:Arial; font-size:9pt">Rodríguez</span><span style="font-family:Arial; font-size:9pt">-Lorenzo, </span><span style="font-family:Arial; font-size:9pt">Álvarez</span><span style="font-family:Arial; font-size:9pt">-Puebla, Liz-</span><span style="font-family:Arial; font-size:9pt">Marzán</span><span style="font-family:Arial; font-size:9pt">, Stevens</span><span style="font-family:Arial; font-size:9pt; font-style:italic"> Nature Materials</span><span style="font-family:Arial; font-size:9pt">, 11, 604 (2012); </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:9pt">Patents: McNeil ‘Resonant Sensor’ PCT/GB02/00237; ‘Dielectric breakdown immunoassay’ UK patent application 9311206.8; </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:9pt">The minimum information about a genome sequence specification. Field et al </span><span style="font-family:Arial; font-size:9pt">Wipat</span><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Nature Biotech. </span><span style="font-family:Arial; font-size:9pt">26, 541 (2008); </span></li><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt">Differentia</span><span style="font-family:Arial; font-size:9pt">l Mode Sensing </span><span style="font-family:Arial; font-size:9pt">Rahal</span><span style="font-family:Arial; font-size:9pt"> &amp; </span><span style="font-family:Arial; font-size:9pt">Demosthenous</span><span style="font-family:Arial; font-size:9pt"> </span><span style="font-family:Arial; font-size:9pt">WO/2009/077759;</span></li><li style="background-color:#ffffff; font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:9pt">Sensors: Good vibrations for Bad Bacteria. McKendry, R.A. &amp; </span><span style="font-family:Arial; font-size:9pt">Kappeler</span><span style="font-family:Arial; font-size:9pt">, N. </span><span style="font-family:Arial; font-size:9pt; font-style:italic">Nature Nanotech.</span><span style="display:none; font-family:Arial; font-size:9pt; font-weight:bold">Volume:</span><span style="font-family:Arial; font-size:9pt; font-weight:bold"> 8</span><span style="font-family:Arial; font-size:9pt">,</span><span style="display:none; font-family:Arial; font-size:9pt">Pages:</span></li></ol><p style="background-color:#ffffff; margin:0pt 0pt 0pt 69.45pt"><span style="font-family:Arial; font-size:9pt"> 483 </span><span style="display:none; font-family:Arial; font-size:9pt">Year published:</span></p><p style="background-color:#ffffff; margin:0pt 0pt 0pt 69.45pt"><span style="font-family:Arial; font-size:9pt">(2013)</span><span style="font-family:Arial; font-size:9pt">;</span></p><ol start="14" type="1" style="margin:0pt; padding-left:0pt"><li style="font-family:Arial; font-size:9pt; list-style-position:inside; margin:0pt 0pt 0pt 54.75pt; text-align:justify; text-indent:0pt"><span style="font-family:Arial; font-size:9pt">ICT Facts and Figures 1013, International Telecommunications Union</span><span style="font-family:Arial; font-size:9pt">;</span></li></ol><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">&#xa0;</span></p><p style="margin:0pt; text-align:justify"><span style="font-family:Arial; font-size:10pt; font-weight:bold">6.0</span><span style="font-family:Arial; font-size:10pt"> </span><span style="font-family:Arial; font-size:10pt; font-weight:bold">Declaration of Interests: </span><span style="font-family:Arial; font-size:10pt">We are a new EPSRC Interdisciplinary Research Collaboration which aims to develop an Early Warning Sensing System for Infectious Diseases. </span><span style="font-family:Arial; font-size:10pt">For more information </span><a name="_GoBack"></a><span style="font-family:Arial; font-size:10pt">please contact the IRC </span><span style="font-family:Arial; font-size:10pt">Director, </span><span style="font-family:Arial; font-size:10pt">Professor Rachel McKendry </span><span style="font-family:Arial; font-size:10pt">(</span><a href="mailto:r.a.mckendry@ucl.ac.uk"><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">r.a.mckendry@ucl.ac.uk</span></a><span style="color:#0000ff; font-family:Arial; font-size:10pt">) </span><span style="font-family:Arial; font-size:10pt">and the Strategic Operations Director, Dr Tania </span><span style="font-family:Arial; font-size:10pt">Saxl</span><span style="font-family:Arial; font-size:10pt"> </span><span style="color:#0000ff; font-family:Arial; font-size:10pt; text-decoration:underline">(t.saxl@ucl.ac.uk</span><span style="font-family:Arial; font-size:10pt">).</span><span style="font-family:Arial; font-size:10pt"> </span></p><p style="margin:0pt; text-align:right"><span style="font-family:Calibri; font-size:11pt">2</span></p><p style="margin:0pt"><span style="font-family:Calibri; font-size:11pt">&#xa0;</span></p></div></body></html>